Integra Lifesciences (IL3) Q2 2026 Earnings Report
DE:IL3 Q2 2026 EPS Results
- Actual EPS
- EUR 0.50
- Consensus EPS
- EUR 0.43
- Beat/Miss
- Beat by +EUR 0.07
- One Year Ago EPS
- EUR 0.40
DE:IL3 Q2 2026 Revenue Results
- Actual Revenue
- EUR 374.85M
- Expected Revenue
- EUR 373.76M
- Beat/Miss
- Beat by +EUR 1.09M
- YoY Revenue Growth
- +0.76%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 07/29/2026
- Time
- Before Open
- Conference Call
- Wednesday, July 29, 2026
DE:IL3 Upcoming Earnings
Integra Lifesciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:IL3 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:IL3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.58- | 0.74 | ― | ― |
| Oct 21, 2026 | 2026 (Q3) | 0.500.53 | 0.48 | 9.26% (+0.04) | |
| Jul 29, 2026 | 2026 (Q2) | 0.430.50 | 0.4 | 24.44% (+0.10) | |
| May 05, 2026 | 2026 (Q1) | 0.360.48 | 0.37 | 31.71% (+0.12) | |
| Feb 26, 2026 | 2025 (Q4) | 0.720.74 | 0.87 | -14.43% (-0.13) | |
| Oct 30, 2025 | 2025 (Q3) | 0.390.48 | 0.37 | 31.71% (+0.12) | |
| Jul 31, 2025 | 2025 (Q2) | 0.390.40 | 0.56 | -28.57% (-0.16) | |
| May 05, 2025 | 2025 (Q1) | 0.390.37 | 0.49 | -25.45% (-0.13) | |
| Feb 25, 2025 | 2024 (Q4) | 0.760.87 | 0.8 | 8.99% (+0.07) | |
| Nov 04, 2024 | 2024 (Q3) | 0.350.37 | 0.68 | -46.05% (-0.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
